T1	Participants 49 88	antihistaminic (H1) effect of bilastine
T2	Participants 166 284	bilastine, a new histamine H(1) receptor antagonist, from single- and multiple-dose studies in healthy adult subjects.
T3	Participants 387 471	In the single-dose studies, a total of 183 subjects received oral doses of bilastine
T4	Participants 524 592	n the multiple-dose studies, 127 healthy subjects received bilastine
T5	Participants 3518 3573	prediction of the pharmacodynamic activity of bilastine
